IOL Chemicals & Pharmaceuticals Ltd
IOL Chemicals & Pharmaceuticals is engaged in the manufacturing and selling of APIs / bulk drugs and specialty chemicals. The company caters to both domestic and international market.
Some of the APIs produced are ibuprofen, metformin hydrochloride, lamotrigine, fenofibrate, and clopidogrel bi sulphate for use in various therapeutic categories, including pain management, anti-diabetic, anti-hypertensive, anti-convulsant, anti-cholesterol, anti-platelet, etc. It also provides specialty industrial chemicals, which include ethyl acetate, iso butyl benzene, acetyl chloride, and mono chloro acetic acid for use in flexible packaging, pharmaceutical, textile, food processing, pesticide, and paint industries.
- Market Cap ₹ 4,116 Cr.
- Current Price ₹ 701
- High / Low ₹ 899 / 146
- Stock P/E 9.30
- Book Value ₹ 186
- Dividend Yield 0.57 %
- ROCE 68.9 %
- ROE 56.9 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 49.30% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 53.19%
- Company's median sales growth is 17.03% of last 10 years
Cons
- No cons found. Suggest something.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Quarterly Results
Figures in Rs. Crores
Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
263 | 288 | 362 | 423 | 478 | 422 | 493 | 449 | 511 | 441 | 460 | 533 | |
231 | 255 | 322 | 348 | 343 | 265 | 348 | 316 | 352 | 305 | 308 | 362 | |
Operating Profit | 32 | 32 | 40 | 75 | 136 | 157 | 145 | 133 | 160 | 137 | 152 | 171 |
OPM % | 12% | 11% | 11% | 18% | 28% | 37% | 29% | 30% | 31% | 31% | 33% | 32% |
Other Income | 1 | 3 | 4 | 6 | 1 | 2 | 3 | 3 | 4 | 5 | 6 | 4 |
Interest | 16 | 15 | 16 | 14 | 13 | 9 | 8 | 6 | 4 | 3 | 2 | 1 |
Depreciation | 8 | 8 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 10 |
Profit before tax | 10 | 13 | 20 | 59 | 115 | 143 | 131 | 121 | 151 | 130 | 147 | 165 |
Tax % | 8% | 10% | 27% | 35% | 29% | 29% | 35% | 28% | 35% | 31% | 13% | 23% |
Net Profit | 9 | 11 | 14 | 38 | 82 | 102 | 85 | 88 | 98 | 90 | 128 | 127 |
EPS in Rs | 1.57 | 2.04 | 2.56 | 6.83 | 14.63 | 17.87 | 15.00 | 15.42 | 17.23 | 15.87 | 21.73 | 21.63 |
Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes |
Profit & Loss
Figures in Rs. Crores
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
301 | 347 | 387 | 471 | 482 | 564 | 385 | 580 | 711 | 983 | 1,685 | 1,894 | 1,946 | |
268 | 309 | 319 | 402 | 392 | 468 | 373 | 529 | 608 | 863 | 1,276 | 1,321 | 1,327 | |
Operating Profit | 33 | 39 | 68 | 69 | 89 | 96 | 11 | 51 | 102 | 120 | 410 | 574 | 620 |
OPM % | 11% | 11% | 18% | 15% | 18% | 17% | 3% | 9% | 14% | 12% | 24% | 30% | 32% |
Other Income | 3 | 1 | 2 | 2 | 3 | 1 | 1 | 1 | 1 | 6 | 10 | 16 | 20 |
Interest | 15 | 15 | 37 | 43 | 57 | 60 | 59 | 61 | 68 | 64 | 51 | 21 | 9 |
Depreciation | 10 | 10 | 24 | 24 | 31 | 32 | 29 | 30 | 30 | 30 | 32 | 36 | 37 |
Profit before tax | 11 | 15 | 9 | 4 | 3 | 5 | -75 | -39 | 6 | 31 | 336 | 533 | 593 |
Tax % | -14% | 32% | 32% | -25% | 46% | 35% | 12% | -4% | 21% | 12% | 30% | 32% | |
Net Profit | 13 | 10 | 6 | 5 | 2 | 3 | -67 | -40 | 5 | 28 | 237 | 361 | 443 |
EPS in Rs | 6.99 | 4.41 | 2.40 | 1.85 | 0.61 | 1.15 | -13.99 | -7.12 | 0.83 | 4.93 | 41.61 | 63.51 | 76.46 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 5% |
Compounded Sales Growth | |
---|---|
10 Years: | 18% |
5 Years: | 38% |
3 Years: | 39% |
TTM: | 6% |
Compounded Profit Growth | |
---|---|
10 Years: | 43% |
5 Years: | 49% |
3 Years: | 323% |
TTM: | 24% |
Stock Price CAGR | |
---|---|
10 Years: | 32% |
5 Years: | 61% |
3 Years: | 107% |
1 Year: | 294% |
Return on Equity | |
---|---|
10 Years: | 22% |
5 Years: | 38% |
3 Years: | 53% |
Last Year: | 57% |
Balance Sheet
Figures in Rs. Crores
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
23 | 28 | 31 | 31 | 31 | 49 | 48 | 56 | 56 | 56 | 57 | 57 | 59 | |
Reserves | 79 | 116 | 140 | 142 | 142 | 160 | 154 | 129 | 132 | 160 | 408 | 747 | 1,036 |
Borrowings | 247 | 269 | 337 | 394 | 400 | 357 | 400 | 453 | 447 | 422 | 284 | 56 | 25 |
75 | 100 | 100 | 124 | 159 | 195 | 100 | 135 | 182 | 214 | 193 | 315 | 334 | |
Total Liabilities | 420 | 508 | 603 | 687 | 727 | 741 | 702 | 772 | 817 | 852 | 942 | 1,176 | 1,454 |
123 | 373 | 351 | 462 | 430 | 411 | 403 | 400 | 374 | 406 | 412 | 469 | 495 | |
CWIP | 187 | 1 | 57 | 12 | 32 | 33 | 4 | 4 | 21 | 7 | 27 | 19 | 20 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
109 | 135 | 195 | 213 | 265 | 297 | 295 | 369 | 422 | 439 | 503 | 687 | 939 | |
Total Assets | 420 | 508 | 603 | 687 | 727 | 741 | 702 | 772 | 817 | 852 | 942 | 1,176 | 1,454 |
Cash Flows
Figures in Rs. Crores
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
16 | 31 | 24 | 55 | 53 | 78 | -47 | 18 | 83 | 120 | 273 | 471 | |
-167 | -67 | -69 | -87 | -18 | -12 | -5 | -27 | -23 | -50 | -63 | -185 | |
154 | 35 | 59 | 23 | -32 | -66 | 50 | 9 | -60 | -70 | -197 | -272 | |
Net Cash Flow | 3 | -0 | 13 | -9 | 3 | 1 | -2 | -0 | 1 | -1 | 13 | 15 |
Ratios
Figures in Rs. Crores
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ROCE % | 10% | 8% | 10% | 9% | 11% | 11% | -3% | 4% | 12% | 15% | 56% | 69% |
Debtor Days | 31 | 32 | 29 | 17 | 27 | 32 | 31 | 55 | 58 | 54 | 43 | 54 |
Inventory Turnover | 5.58 | 4.62 | 3.32 | 3.01 | 2.34 | 2.33 | 1.62 | 2.09 | 2.10 | 3.15 | 5.61 | 6.01 |
Documents
Add documentRecent announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 6h
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 1d
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 1d
- Announcement under Regulation 30 (LODR)-Newspaper Publication 19 Jan
- Statement Of Investor Complaints For The Quarter Ended December 2020 18 Jan
View all
Annual reports
- Financial Year 2020 from bse
- Financial Year 2019 from bse
- Financial Year 2018 from bse
- Financial Year 2017 from bse
- Financial Year 2016 from bse
- Financial Year 2015 from bse
- Financial Year 2014 from bse
- Financial Year 2013 from bse
- Financial Year 2012 from bse
- Financial Year 2011 from bse
- Financial Year 2010 from bse